MaxCyte, Inc.

AIM:MXCT 주식 보고서

시가총액: UK£309.5m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

MaxCyte 관리

관리 기준 확인 2/4

MaxCyte's CEO는 Maher Masoud, Jan2024 에 임명되었습니다 의 임기는 1년 미만입니다. 총 연간 보상은 $ 890.37K, 50.5% 로 구성됩니다. 50.5% 급여 및 49.5% 보너스(회사 주식 및 옵션 포함). 는 £ 369.99K 가치에 해당하는 회사 주식의 0.096% 직접 소유합니다. 369.99K. 경영진과 이사회의 평균 재임 기간은 각각 1 년과 3 년입니다.

주요 정보

Maher Masoud

최고 경영자

US$890.4k

총 보상

CEO 급여 비율50.5%
CEO 임기less than a year
CEO 소유권0.1%
경영진 평균 재임 기간1.3yrs
이사회 평균 재임 기간3.3yrs

최근 관리 업데이트

Recent updates

MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 09
MaxCyte, Inc. (LON:MXCT) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

May 30
Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27%

Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

May 10
Analysts Are Upgrading MaxCyte, Inc. (LON:MXCT) After Its Latest Results

Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Mar 14
Downgrade: Here's How Analysts See MaxCyte, Inc. (LON:MXCT) Performing In The Near Term

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 07
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Oct 07
Analysts Have Just Cut Their MaxCyte, Inc. (LON:MXCT) Revenue Estimates By 22%

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Aug 12
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

May 15
MaxCyte, Inc. (LON:MXCT) Analysts Just Slashed This Year's Revenue Estimates By 11%

Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

May 14
Investors Don't See Light At End Of MaxCyte, Inc.'s (LON:MXCT) Tunnel And Push Stock Down 28%

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Apr 27
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Nov 20
Companies Like MaxCyte (LON:MXCT) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

Mar 02
Here's Why We're Not Too Worried About MaxCyte's (LON:MXCT) Cash Burn Situation

We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

Nov 17
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth

We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

Jul 25
We're Not Worried About MaxCyte's (LON:MXCT) Cash Burn

MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

Feb 22
MaxCyte (LON:MXCT) Shareholders Have Enjoyed A Whopping 545% Share Price Gain

CEO 보상 분석

Maher Masoud 의 보수는 MaxCyte 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-US$35m

Mar 31 2024n/an/a

-US$37m

Dec 31 2023US$890kUS$450k

-US$38m

Sep 30 2023n/an/a

-US$37m

Jun 30 2023n/an/a

-US$33m

Mar 31 2023n/an/a

-US$30m

Dec 31 2022US$791kUS$413k

-US$24m

보상 대 시장: Maher 의 총 보상 ($USD 890.37K )은 UK 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 988.57K ).

보상과 수익: 회사가 수익성이 없는 동안 Maher 의 보상이 증가했습니다.

CEO

Maher Masoud (49 yo)

less than a year

테뉴어

US$890,365

보상

Mr. Maher Masoud is President, CEO & Executive Director of MaxCyte, Inc. since January 1, 2024 and served as its Head of Global Business Development and Legal Officer since November 2023 and had been its S...

리더십 팀

이름위치테뉴어보상소유권
Maher Masoud
Presidentless than a yearUS$890.37k0.095%
$ 294.0k
Douglas Doerfler
Founder26.2yrsUS$3.14m0.32%
$ 979.6k
Douglas Swirsky
Chief Financial Officer1.5yrsUS$1.29m데이터 없음
Jay Gelfman
Senior Vice President of Operationsless than a year데이터 없음데이터 없음
Ronald Holtz
Executive Vice President of Administration1.5yrsUS$948.33k데이터 없음
David Sandoval
Senior Vice Presidentless than a year데이터 없음데이터 없음
Thomas Ross
Executive Vice President of Global Sales10yrs데이터 없음0.024%
$ 73.5k
Jack Horgan
Vice President of Corporate Developmentless than a year데이터 없음데이터 없음
Jill Mayer
Senior Vice President of Human Resourcesless than a year데이터 없음데이터 없음
J. Thompson
Consultant2.9yrsUS$264.50k데이터 없음
James Brady
Senior VP of Technical Applications & Customer Support3.1yrs데이터 없음데이터 없음
Ali Soleymannezhad
Executive VP of Bioprocessing1.1yrs데이터 없음데이터 없음

1.3yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 관리: MXCT 의 관리팀은 경험 (평균 재직 기간 1 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름위치테뉴어보상소유권
Maher Masoud
Presidentless than a yearUS$890.37k0.095%
$ 294.0k
William Brooke
Independent Non-Executive Director20.5yrsUS$177.24k0.048%
$ 147.9k
Arthur Mandell
Independent Non-Executive Director18.3yrsUS$170.49k0.36%
$ 1.1m
Patrick Balthrop
Independent Non-Executive Director1.8yrsUS$155.49k0%
$ 0
Richard Douglas
Independent Non-Executive Chairman of the Board6.6yrsUS$190.49k0.095%
$ 294.0k
Stanley Erck
Independent Non-Executive Director19.5yrsUS$162.24k0.24%
$ 728.4k
John Johnston
Independent Non-Executive Director8.7yrsUS$160.49k0.11%
$ 354.5k
Yasir Al-Wakeel
Independent Non-Executive Director3.3yrsUS$238.53k0%
$ 0
Rekha Hemrajani
Independent Non-Executive Director3.3yrsUS$243.03k0%
$ 0
Marcela Maus
Member of Scientific Advisory Board1.5yrs데이터 없음데이터 없음
Cenk Sumen
Member of Scientific Advisory Boardless than a yearUS$897.25k0%
$ 0
Oliver Rando
Member of Scientific Advisory Board1.5yrs데이터 없음데이터 없음

3.3yrs

평균 재임 기간

65yo

평균 연령

경험이 풍부한 이사회: MXCT 의 이사회는 경험(평균 재직 기간 3 년)으로 간주됩니다.